Pictet Asset Management (UK)’s Impax Laboratories, Inc. IPXL Stock Holding History

Pictet Asset Management (UK)’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-79,785	Closed	-$1.89M	–	878
2016 Q3	$1.89M	Buy	79,785 +4,100	+5%	+$110K	0.01%	739
2016 Q2	$2.58M	Sell	75,685 -36,015	-32%	-$1.17M	0.01%	708
2016 Q1	$3.65M	Buy	111,700 +2,600	+2%	+$91.4K	0.02%	595
2015 Q4	$4.67M	Buy	109,100 +5,700	+6%	+$228K	0.02%	564
2015 Q3	$3.64M	Sell	103,400 -9,200	-8%	-$414K	0.02%	624
2015 Q2	$5.46M	Buy	+112,600	New	+$5.34M	0.02%	567
2015 Q1	–	Sell	-13,800	Closed	-$437K	–	902
2014 Q4	$437K	Hold	13,800	–	–	﹤0.01%	833
2014 Q3	$327K	Sell	13,800 -198,400	-93%	-$5.08M	﹤0.01%	831
2014 Q2	$6.36M	Buy	212,200 +46,300	+28%	+$1.25M	0.03%	487
2014 Q1	$4.38M	Buy	165,900 +6,300	+4%	+$157K	0.02%	565
2013 Q4	$4.01M	Sell	159,600 -78,600	-33%	-$1.75M	0.02%	575
2013 Q3	$4.89M	Sell	238,200 -120,800	-34%	-$2.49M	0.03%	513
2013 Q2	$7.16M	Buy	+359,000	New	+$6.37M	0.04%	395

Other funds holding IPXL

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pictet Asset Management (UK)'s IPXL Position: Q4 2016 in Review

Pictet Asset Management (UK) sold out of Impax Laboratories, Inc. (IPXL) in Q4 2016, closing a stake of 79,785 shares — an estimated $1.89M sold.

Pictet Asset Management (UK) first reported a position in IPXL in Q2 2013 and held it in 13 quarters. The position peaked at $7.16M in Q2 2013. 198 funds tracked by Wall St. Rank hold IPXL as of Q4 2016.

Pictet Asset Management (UK) reported no remaining Impax Laboratories, Inc. position as of Q4 2016 after selling out during the quarter.
Pictet Asset Management (UK) sold 79,785 Impax Laboratories, Inc. shares in Q4 2016, an estimated $1.89M.
Pictet Asset Management (UK) first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 13 quarters.
Pictet Asset Management (UK)'s Impax Laboratories, Inc. position peaked at $7.16M in Q2 2013.
198 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2016.

Based on Pictet Asset Management (UK)'s 13F filing for Q4 2016, filed 13 Feb 2017.